PHIO

#4758
Phio Pharmaceuticals Corp. Common Stock
1.2750 USD
-1.16%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
1.2500
1.2750
년간 변동
0.9780
1.3500
일일 변동
-1.16%
월간 변동
+5.37%
6달 변화
+7.14%
년간 변동율
+7.14%
이전 종가
1.2900
Open
1.2700
Bid
Ask
Low
1.2500
High
1.2750
양
8
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Phio Pharmaceuticals Corp

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

뉴스